Form 8-K Baudax Bio, Inc. For: Feb 22
FREE Breaking News Alerts from StreetInsider.com!
StreetInsider.com Top Tickers, 6/11/2026
- Wall St set to gain on tech rebound, Middle East in focus
- SpaceX prices historic IPO at $135/share in largest ever new listing
- Oil drops as Trump cancels planned strikes against Iran
- Intel rallies as BofA double-upgrades stock on increased CPU, foundry visibility
- Oppenheimer sees little strategic case for Tesla-SpaceX merger
- Needham Starts Hyliion Holdings (HYLN) at Buy
- Adobe CFO Dan Durn to depart company in June 2026
- Oppenheimer Starts SpaceX (SPCX) at Outperform, PT $190, 'space infrastructure appears structurally advantaged'
- Pentagon reportedly locked down, hazmat teams responding
- Alibaba falls on China AI capex report; Citi says selloff is premature
Baudax Bio (BXRX) Files Chapter 11
February 28, 2024 6:17 AM ESTOn February 22, 2024, Baudax Bio (NASDAQ: BXRX) filed a voluntary petition under Chapter 11 of the U.S. Bankruptcy code (the Bankruptcy Code) in the U.S. Bankruptcy Court for the Eastern District of Pennsylvania (the Bankruptcy Court) (the Chapter 11 Case). The Chapter 11 Case was assigned case number... More
